DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.
Algorithms
Brachytherapy
/ methods
Computer Simulation
Humans
Image Processing, Computer-Assisted
/ methods
Male
Monte Carlo Method
Phantoms, Imaging
Prostate
/ radiation effects
Prostatic Neoplasms
/ radiotherapy
Quality Control
Radiometry
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
/ methods
Reproducibility of Results
Software
Journal
International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
07
05
2018
revised:
12
09
2018
accepted:
28
09
2018
pubmed:
14
10
2018
medline:
6
8
2019
entrez:
14
10
2018
Statut:
ppublish
Résumé
Inverse planning is an integral part of modern low-dose-rate brachytherapy. Current clinical planning systems do not exploit the total dose information and largely use the American Association of Physicists in Medicine TG-43 dosimetry formalism to ensure clinically acceptable planning times. Thus, suboptimal plans may be derived as a result of TG-43-related dose overestimation and nonconformity with dose distribution requirements. The purpose of this study was to propose an inverse planning approach that can improve planning quality by combining dose-volume information and precision without compromising the overall execution times. The dose map was generated by accumulating precomputed Monte Carlo (MC) dose kernels for each candidate source implantation site. The MC computational burden was reduced by using graphics processing unit acceleration, allowing accurate dosimetry calculations to be performed in the intraoperative environment. The proposed dose-volume histogram (DVH) fast simulated annealing optimization algorithm was evaluated using clinical plans that were delivered to 18 patients who underwent low-dose-rate prostate brachytherapy. Our method generated plans in 37.5 ± 3.2 seconds with similar prostate dose coverage, improved prostate dose homogeneity of up to 6.1%, and lower dose to the urethra of up to 4.0%. A DVH-based optimization algorithm using MC dosimetry was developed. The inclusion of the DVH requirements allowed for increased control over the optimization outcome. The optimal plan's quality was further improved by considering tissue heterogeneity.
Identifiants
pubmed: 30315873
pii: S0360-3016(18)33832-X
doi: 10.1016/j.ijrobp.2018.09.041
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
503-510Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.